Volume 15, Number 8—August 2009
Research
Transgenic Mice Expressing Porcine Prion Protein Resistant to Classical Scrapie but Susceptible to Sheep Bovine Spongiform Encephalopathy and Atypical Scrapie
Table
TSE isolate | Genotype | PrPres, kDa | First passage |
Second passage |
Third passage |
|||||
---|---|---|---|---|---|---|---|---|---|---|
Survival time, dpi | % (Attack rate) | Survival time, dpi | % (Attack rate) | Survival time, dpi | % (Attack rate) | |||||
Cattle-BSE1 | – | 19 | >650 | 0 (0/12)† | 269 ± 3 | 100 (10/10) | 204 ± 12 | 100 (9/9) | ||
Cattle-BSE2 | – | 19 | 498 ± 9 | 17 (2/12)† | 198 ± 6 | 100 (15/15) | 193 ± 17 | 100 (6/6) | ||
Cattle-BSE0 | – | 19 | >650 | 19 (3/16)† | 197 ± 4 | 100 (12/12) | 190 ± 10 | 100 (7/7) | ||
Sheep-BSE0 | ARQ/ARQ | 19 | 458 ± 11 | 100 (15/15) | 162 ± 4 | 100 (13/13) | 166 ± 7 | 100 (7/7) | ||
SC-662/97 | ARQ/ARQ | 21 | >650 | 0 (0/10) | >650 | 0 (0/12) | ND | ND | ||
SC-UCD/99 | ARQ/ARQ | 21 | >650 | 0 (0/12) | >650 | 0 (0/9) | ND | ND | ||
SC-Langlade | ARQ/ARQ | 21 | >650 | 0 (0/12) | >650 | 0 (0/12) | ND | ND | ||
SC-PS13 | ARQ/ARQ | 20 | >650 | 0 (0/12) | >650 | 0 (0/12) | ND | ND | ||
SC-JR01 | VRQ/VRQ | 21 | >650 | 0 (0/12) | >650 | 0 (0/12) | ND | ND | ||
SC-PS83 | ARR/ARR | 21 | >650 | 0 (0/12) | >650 | 0 (0/12) | ND | ND | ||
SC-PS48 | VRQ/VRQ | 19 | >650 | 0 (0/9) | >650 | 0 (0/10) | ND | ND | ||
SC-PS152 | AfRQ/AfRQ | ≈7–14 | 300–600 | 16 (2/12) | 162 ± 13 | 100 (9/9) | 172 ± 16 | 100% (7/7) | ||
SC-UCD/99 adapted to BoPrP-Tg110 | –- | >650 | 0 (0/13) | >650 | 0 (0/10) | ND | ND | |||
Healthy sheep brain | ARQ/ARQ | >650 | 0 (0/14) | >650 | 0 (0/9) | ND | ND |
*BSE, bovine spongiform encephalopathy; TSE, transmissible spongiform encephalopathy; PrPres, atypical proteinase K–resistant prion protein; dpi, days postinoculation; ND, not determined.
†No. animals positive for the aberrant form of PrP associated with disease / no. inoculated animals.
Page created: October 04, 2010
Page updated: October 04, 2010
Page reviewed: October 04, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.